Dehydration and shock: an animal model of hemorrhage and resuscitation of battlefield injury.
We have developed a porcine model of the anticipated military use of oxygen-carrying resuscitation solutions. The objective is to determine whether toxicity under adverse conditions will limit further development of hemoglobin-based products. Splenectomized immature female swine are used because of their extensive use in the evaluation of other resuscitation solutions. Five days prior to each experiment, central vascular catheters and a renal arterial flow probe are surgically placed in the animals. After recovery and weight gain has resumed, animals are placed in metabolic cages and deprived of water for 48 hours to produce hyperosmolar dehydration resulting in loss of approximately 7% of body weight. We remove 38% of estimated blood volume, 25 ml/kg, over one hour by a controlled logarithmic hemorrhage. Resuscitation is by administration of a fixed volume of test solution. Hemodynamic function is observed but not further therapy is given for three hours, a period corresponding to evacuation in the field. After this period, corresponding to arrival at a field hospital, the animals' blood is returned. Swine are then observed in metabolic cages for an additional 7 days while blood and urine are sampled daily. At the end of this period, animals are anesthetized, urinary catheters are implanted, and creatinine clearances are measured. Swine are than euthanized, and their tissues are examined. In a pilot study, resuscitation was performed with either Ringer's lactate, albumin, stroma-free hemoglobin, or cross-linked (alpha alpha Hb) hemoglobin. All animals survived.
Hess
J R
JR
Blood Research Division, Letterman Army Institute of Research, San Francisco, California 94129-6800.
MacDonald
V W
VW
Winslow
R M
RM
D000818:Animals; D001802:Blood Substitutes / Q000627:therapeutic use*; D003681:Dehydration / Q000628:therapy*; D004195:Disease Models, Animal; D005260:Female; D006454:Hemoglobins / Q000627:therapeutic use*; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D012151:Resuscitation; D012769:Shock / Q000628:therapy*; D013552:Swine; D014857:Warfare; D014947:Wounds and Injuries / Q000628:therapy
D001802:Blood Substitutes; D006454:Hemoglobins